Bill number does not exist. Enter a vaild keyword.
Original
Chamber
1st
Reading
Referral
to Cmte
2nd
Reading
3rd
Reading
Opposite
Chamber
1st
Reading
Referral
to Cmte
2nd
Reading
3rd
Reading
Review in
Original Chamber
Passed Both
Chambers
Conf. Cmte
(if necessary)
To Governor
Title
Prescription Drug Affordability Board - Authority for Upper Payment Limits and Funding (Lowering Prescription Drug Costs for All Marylanders Act of 2024)
Sponsored by
Senators Gile, Feldman, Beidle, Ellis, Guzzone, Hester, Hettleman, Jackson, Klausmeier, Kramer, and Lam
Status
In the Senate - Hearing 2/07 at 2:00 p.m. (Finance)
Analysis
Fiscal and Policy Note
Synopsis
Requiring the Governor in fiscal year 2025 and each fiscal year thereafter to include in the annual budget bill an appropriation of at least $1,000,000 for the Prescription Drug Affordability Fund which provides funding for the Board; and requiring the Board, under certain circumstances, to establish a process for setting upper payment limits for all purchases and payor reimbursements of prescription drug products in the State that the Board determines have led or will lead to affordability challenges.
Details
Cross-filed with: HB0340
Bill File Type: Regular
Effective Date(s): October 1, 2024
Bill imposes a mandated appropriation in the annual State Budget Bill
Legislation History
Chamber
Senate
Calendar Date
1/18/2024
Legislative Date
1/18/2024
Action
First Reading Finance and Budget and Taxation
Proceedings
Chamber
Senate
Calendar Date
1/24/2024
Legislative Date
1/24/2024
Action
Hearing 2/07 at 2:00 p.m. (Finance)
Proceedings
Chamber Calendar Date Legislative Date Action Proceedings
Senate 1/18/2024 1/18/2024 First Reading Finance and Budget and Taxation
Text - First - Prescription Drug Affordability Board - Authority for Upper Payment Limits and Funding (Lowering Prescription Drug Costs for All Marylanders Act of 2024)
Senate 1/24/2024 1/24/2024 Hearing 2/07 at 2:00 p.m. (Finance)
Last Updated: 4/1/2024 1:46 PM
Click to return on the top page